Propulsid

Propulsid (Cisapride) may cause irregular heartbeats and even sudden death. At least 341 reports of heart-rhythm abnormalities, including 80 reports of deaths, have been associated with Propulsid. Although the FDA first warned that Propulsid can cause serious heart problems in June 1998, reports of deaths and hospitalizations have continued to mount.

Some 30 million U.S. residents, including President Clinton, have taken the medication since it hit the market in 1993 for Gastroesophageal Reflux Disease (GERD).

If you believe that you or a loved one has been injured by a product containing Propulsid consult a lawyer to learn your legal rights.

Propulsid can cause serious side effects such as:

After the drug's approval in 1993, there were several revisions to the Propulsid label, informing health care professionals and patients about various side effects and risks, the most serious of which involved cardiac irregularities.

Although Propulsid was only associated with mild adverse effects upon approval, the drug was soon linked to life-threatening heart rhythm abnormalities (arrhythmias) and cardiac arrest in people with no prior heart disease. After years of escalating fatalities and pressure from the FDA, Janssen Pharmaceutical Inc., a division of Johnson & Johnson, announced that it would voluntarily stop marketing Propulsid in the United States beginning July 14, 2000.

FDA Drug Safety Report

< BACK

We bring this important information to your attention to better educate you about the risks and dangers of prescription and pharmaceutical drugs.

PRESCRIPTION DRUG QUESTIONS & ANSWERS

- Arava FAQs
- Meridia FAQs
- Prempro FAQs
- Vioxx FAQs